Hyundai Bioland Logo

Site map
EN KR CH

Advanced Regenerative Medicine

Advanced Regenerative Medicine
Advanced Medical Materials
Securing technologies for medical materials for dentistry, orthopedics, and dermatology, based on collagen and hyaluronic acid.
Securing formation technologies, including sheet, sponge, and injection types, applying various biomaterials.

・ Key Materials

Dentistry

Collagen /
Bone graft material

Technology for regenerating
periodontal tissue (FDA, CE)

Collagen membrane ¹⁾

Induce the regeneration of collagen-based barrier membrane and alveolar bone

Bone graft material

Promote the regeneration of bone and collagen-based bone graft material
and alveolar bone ²⁾

Orthopedics

Collagen / BioCeramic /
Polymer

Technological development
of replacements forbone
and cartilage defects

Technology for forming collagen injection for tissue regeneration

Collagen-based replacement of ligament and tendon defects

Prosthetics/vertebroplasty bone cement

PMMA, MMA and gentamicin combined technology

Implant fixed on bone

Synthetic bone graft materials
for the formation of new bones

Maintain stable volume using β-TCP+HAp

Secure excellent bone absorption and regeneration technology

Dermatology

Collagen /
Hyaluronic acid / Silicone

Securing technologies for medical
materials for injuries, scars,
and beauty purposes

Wound dressing³⁾ for healing burns and wounds

Technology for manufacturing collagen and hyaluronic acid-based wound dressing
Artificial dermis and promotion of dermal regeneration for burn treatment

Silicone-material technology excellent in scar treatment

Protection and recovery of scars through silicone hardening technology

¹⁾ Collagen membrane: Protective layer to cover the affected area after implant and soft tissue surgery

²⁾ Alveolar bone graft material: Heterogeneous bone graft material for dentistry

³⁾ Wound dressing: Medical material that helps in the regeneration of damaged skin due to burns or ulcer

Hemostat
Development of high-performance non-blood hemostats by securing the proprietary technology for core materials with hemostatic performance.
This differentiated liquid hemostatic agent instantly forms a gel substance upon contact with blood, compressing the bleeding site to induce effective hemostasis.

・ Advanced Surgical Hemostats

Stem cell
Cell therapeutics (Production Process)

Regeneration

Cartilage Regeneration Treatment

Establishment of clinical research competency and pipeline through open innovation.

Indication expansion of Cartistem1)

for treatment of cartilage defects on ankle joint.

1) Cartistem: Stem cell therapeutic product for knee cartilage regeneration in patients with defected cartilage.
It is developed and manufactured by MEDIPOST Co., Ltd.

Phase 3 clinical trial is ongoing in Korea.

Immune Modulation

Atopic Dermatitis Treatment

Securing manufacturing license and pipeline through open innovation

Treatment for moderate-to-severe atopic dermatitis via immune and inflammation modulation.

Core Platform

HDB Future Bio Core Technology

Development of HDB’s Cell therapy platform with multifunction and high efficiency.

Establishment of technologies for activating and controlling the function of cellular active ingredients

Maximization of therapeutic efficacy by strengthening anti-inflammatory and tissue regeneration functions

Expansion of pipeline based on definitive mechanism analysis

(cardiovascular system, central nervous system, etc.)